GIONCO DAVID (Chief Accounting Officer) sold 0.9% of their position (2.85K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $11.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/20/2020ACC: 0001104659-20-037012
Officer· Chief Accounting Officer
Since Feb 2019
-2.85K
Net shares
Net seller
$11.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.85K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.85K
Price / share
$3.88
Trade value
$11.05K
% of position
0.9%
3/16/2020
319.73K→316.88K
Total
Net shares
−2.85K
Net value
-$11.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2020 | S · Sale | −2.85K | $3.88 | $11.05K | 0.9% | 319.73K | 316.88K |
| Total | −2.85K | -$11.05K | ||||||
Derivative Transactions0
No derivative transactions reported